• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-Q180V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Inflammation (1932); Perforation (2001)
Event Type  Injury  
Event Description
It was reported olympus medical systems corp.(omsc) received literature titled "technical evaluation of duodenoscope performance using a newly developed assessment tool".The study aimed to assess the reliability of newly designed assessment tool to measure the technical performance of duodenoscopes.The duodenoscope assessment tool (dat) evaluated the performance of conventional reusable duodenoscopes (tjf 180, olympus america) in 745 patients who underwent endoscopic retrograde cholangiopancreatographys (ercps) at 7 tertiary medical centers over a 6-month period.The median number of cannulation attempt was 1 (interquartile range 1-4) with overall cannulation rate of 98.1%.Adverse events included: bleeding in 17 patients; perforation in 3 patients; acute pancreatitis in 18 patients; infection in 3 patients.The study concluded the newly developed dat represents a reliable measure of the performance of a duodenoscope in patients undergoing ercp.Dat will potentially enable the objective comparison of duodenoscope performances and provide a framework for technical evaluation of other types of endoscopes.The devices were not returned to olympus for evaluation and no device serial numbers were provided.The cause of the reported event cannot be determined.If additional information becomes available at a later time, this report will be supplemented.The risks of ercp include complications such as the following: ¿pancreatitis (inflammation of the pancreas); ¿infection of the bile ducts or gallbladder; ¿excessive bleeding, called hemorrhage; ¿an abnormal reaction to the sedative, including respiratory or cardiac problems; ¿perforation in the bile or pancreatic ducts, or in the duodenum.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
MDR Report Key10267839
MDR Text Key198682023
Report Number2951238-2020-00478
Device Sequence Number1
Product Code FDT
UDI-Device Identifier04953170339967
UDI-Public04953170339967
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 06/15/2020,07/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-Q180V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date06/15/2020
Event Location Hospital
Date Report to Manufacturer06/15/2020
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-